KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Consolidated Net Income: 2010-2025

Historic Consolidated Net Income for Novavax (NVAX) over the last 16 years, with Sep 2025 value amounting to -$202.4 million.

  • Novavax's Consolidated Net Income fell 66.84% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 219.97%. This contributed to the annual value of -$187.5 million for FY2024, which is 65.60% up from last year.
  • As of Q3 2025, Novavax's Consolidated Net Income stood at -$202.4 million, which was down 290.01% from $106.5 million recorded in Q2 2025.
  • Novavax's Consolidated Net Income's 5-year high stood at $518.6 million during Q1 2025, with a 5-year trough of -$846.3 million in Q4 2021.
  • Over the past 3 years, Novavax's median Consolidated Net Income value was -$121.3 million (recorded in 2024), while the average stood at -$28.2 million.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first slumped by 1,910.83% in 2021, then surged by 451.51% in 2025.
  • Novavax's Consolidated Net Income (Quarterly) stood at -$846.3 million in 2021, then surged by 78.46% to -$182.2 million in 2022, then climbed by 2.12% to -$178.4 million in 2023, then surged by 54.58% to -$81.0 million in 2024, then slumped by 66.84% to -$202.4 million in 2025.
  • Its last three reported values are -$202.4 million in Q3 2025, $106.5 million for Q2 2025, and $518.6 million during Q1 2025.